0

Artificial Organs Market by Product, Usage, and Geography - Forecast and Analysis 2023-2027

  • Published: Jan 2023
  • Pages: 170
  • SKU: IRTNTR44011
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The artificial organs market is estimated to grow at a CAGR of 9.14% between 2022 and 2027. The size of the market is forecast to increase by USD 13,089.17 million. The growth of the market depends on serval factors, including the increasing prevalence of chronic disorders, shortage of organ donors, and growing demand for pacemakers and dialyzers.

This report extensively covers market segmentation by product (artificial heart, artificial kidney, cochlear implants, and artificial pancreas), usage (implantable and extracorporeal), and geography (North America, Europe, Asia, and the Rest Of World (ROW)).  It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the size of the Artificial Organs Market During the Forecast Period?

Artificial Organs Market Size

To learn more about this report, Download Report Sample

Parent Market Analysis

The reports categorize the global artificial organs market as a part of the global healthcare supplies market that primarily covers manufacturers of medical products, including all categories of supplies, such as consumables and disposables, such as safety needles, syringes, and catheters. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.

Artificial Organs Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increasing prevalence of chronic disorders is notably driving the market growth, although factors such as complications and limitations of artificial organs may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Artificial Organs Market Driver

The increasing prevalence of chronic disorders is one of the key factors driving the growth of the market. The increase in the prevalence of diabetes, chronic kidney diseases, hearing disorders, and cardiovascular diseases (CVDs), such as strokes and cardiac diseases, and the rise in the aging population is likely to increase the demand for artificial organs. The increase in physical inactivity and unhealthy diets will result in high blood pressure, high blood glucose, and high lipids leading to hypertension, obesity, abnormal cholesterol, and diabetes problems. These factors lead to cardiac disorders among people, especially those aged 60 years and above.

In recent years, the incidence and prevalence of CVDs such as strokes, myocardial infarction, and CADs have increased. The rise in the incidence of cardiovascular diseases has led to an increase in demand for devices such as pacemakers and total artificial hearts. Thus, the increase in the prevalence of chronic diseases is the major factor that is expected to drive the growth of the market during the forecast period.

Significant Artificial Organs Market Trend

 

The emergence of TAH  is the primary trend in the market. An effective treatment option that has emerged promising for patients with end-stage biventricular heart failure awaiting orthotopic heart transplantation is total artificial hearts. The number of patients with end-stage heart failure awaiting heart transplantation exceeds the number of hearts available for transplant. This is due to the increased incidence of cardiovascular diseases and is resulting in increased use of mechanical circulatory support devices such as TAH.

Recently, a multi-centered, post-market approval study was conducted for a comparable BTT rate. Accordingly, around 1,100 TAH implantations were performed in the past few years. TAH has resulted in great efficacy in supporting patients with acute irreversible heart failure associated with massive acute myocardial infarction. CARMAT's total artificial heart is in the clinical development phase and is yet to obtain a CE (Conformite Europeenne) marking from the EU (European Union). This will have a significant impact on the growth of the market during the forecast period.

Major Artificial Organs Market Challenge

The complications and limitations of artificial organs are a major challenge for market growth. The purpose of artificial organs is to replace the damaged or diseased organ so that the functions of the replaced organ are restored. Though artificial organs can save the life of a person, their benefit is not as apparent as it may seem. Artificial organs are associated with various complications and limitations.

Complications related to the transplant procedure are uncommon but include bleeding, infection, operative difficulty, device malfunctioning, and blood clotting arising from the blood flow over non-biological surfaces. The most common complications noticed in people implanted with TAH include bleeding, thrombosis, infections, liver failure, renal failure, and neurological events such as stroke and device malfunction. Infectious and hemorrhagic complications are rarely reported as major causes of death due to artificial organ implantation. However, these factors will hinder the market growth during the forecast period.

Key Artificial Organs Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Artificial Organs Market Share by Geography

Global Artificial Organs Market Customer Landscape

Who are the Major Artificial Organs Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - The company offers artificial organs that include gut microbiome which is comprised of an ecosystem of microbes like bacteria, fungi, and viruses that naturally live both on and within us, protecting us against harmful germs and helping break down our food to release energy.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • BIOTRONIK SE and Co. KG
  • BiVACOR Inc.
  • Boston Scientific Corp.
  • Cochlear Ltd.
  • F. Hoffmann La Roche Ltd.
  • Fresenius Medical Care AG and Co. KGaA
  • Insulet Corp.
  • MED EL Elektromedizinische Gerate GmbH
  • Medtronic Plc
  • Nihon Kohden Corp.
  • Nikkiso Co. Ltd.
  • Nipro Pharma Packaging International NV
  • Sonova AG
  • SynCardia Systems LLC
  • Tandem Diabetes Care Inc.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Artificial Organs Market?

The market share growth of the artificial heart segment will be significant during the forecast period. This is due to the limited availability of heart donors, the increasing number of cardiovascular diseases, and technological advances. For instance, according to the CDC, every year, about 735,000 people in the US have a heart attack, of which 525,000 are first heart attacks and 210,000 are recurrent heart attacks. In addition, growing awareness and government initiatives to improve healthcare facilities are driving the global artificial heart market.

Artificial Organs Market Size

Get a glance at the market contribution of various segments Request a PDF Sample

The artificial heart segment was valued at USD 7,374.95 million in 2017 and continued to grow until 2021The growing demand and technological advances in implantable cardiac pacemakers have increased their adoption, which will help the market achieve the fastest growth rate during the forecast period. Syncardia's 70cc TAH and 50cc TAH; BiVACOR's TAH, which is designed to be a long-term device that can replace the total function of the patient's native heart; and Medtronic's Micra Transcatheter Pacing System (TPS), which is the world's smallest pacemaker with a 99% implant success rate in 726 patients, are some of the implantable cardiac pacemakers available in the market.

Which are the Key Regions for the Artificial Organs Market?

Artificial Organs Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 46% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The artificial organs market in North America will grow at a significant pace during the forecast period. The US holds the largest market share in the region, followed by Canada. The growth of the market in the region is driven by the increasing adoption of technologically advanced devices, the increasing number of product launches, and the strong presence of vendors in the market. The growing prevalence and incidence of chronic diseases such as diabetes, cardiovascular diseases, and CKD also contribute to the growth of the market in the region. Moreover, owing to the high prevalence of CKD and the availability of advanced technologies and services, key vendors are reporting a majority of revenue from North America. Therefore, with such increasing organic growth, the artificial organs market is expected to increase in the region during the forecast period.

COVID-19 in 2020 severely impacted the artificial organs market in North America. However, companies are investing heavily in R&D to find a feasible way to treat disabilities. Such factors are expected to open up new opportunities for artificial organs and will drive the growth of the artificial organs market in North America during the forecast period.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Product Outlook (USD Million, 2017 - 2027)
    • Artificial heart
    • Artificial kidney
    • Cochlear implants
    • Artificial pancreas
  • Usage Outlook (USD Million, 2017 - 2027)
    • Implantable
    • Extracorporeal
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina
      • Rest of the Middle East & Africa

Artificial Organs Market Scope

Report Coverage

Details

Page number

170

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 9.14%

Market growth 2023-2027

USD 13,089.17 million

Market structure

Fragmented

YoY growth 2022-2023(%)

8.56

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 46%

Key countries

US, Germany, UK, France, and Japan

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Asahi Kasei Corp., B. Braun SE, Baxter International Inc., BioTelemetry Inc., BIOTRONIK SE and Co. KG, BiVACOR Inc., Boston Scientific Corp., Cochlear Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, Insulet Corp., MED EL Elektromedizinische Gerate GmbH, Medtronic Plc, Nihon Kohden Corp., Nikkiso Co. Ltd., Nipro Pharma Packaging International NV, Sonova AG, SynCardia Systems LLC, and Tandem Diabetes Care Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Artificial Organs Market Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the artificial organs market between 2023 and 2027
  • Precise estimation of the artificial organs market size and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of artificial organs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Usage
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global artificial organs market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global artificial organs market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 Usage Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Usage Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Artificial heart - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Artificial heart - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Artificial heart - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Artificial heart - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Artificial heart - Year-over-year growth 2022-2027 (%)
    • 6.4 Artificial kidney - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Artificial kidney - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Artificial kidney - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Artificial kidney - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Artificial kidney - Year-over-year growth 2022-2027 (%)
    • 6.5 Cochlear implants - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Cochlear implants - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Cochlear implants - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Cochlear implants - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Cochlear implants - Year-over-year growth 2022-2027 (%)
    • 6.6 Artificial pancreas - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Artificial pancreas - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Artificial pancreas - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Artificial pancreas - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Artificial pancreas - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by Product
      • Exhibit 50: Market opportunity by Product ($ million)

    7 Market Segmentation by Usage

    • 7.1 Market segments
      • Exhibit 51: Chart on Usage - Market share 2022-2027 (%)
      • Exhibit 52: Data Table on Usage - Market share 2022-2027 (%)
    • 7.2 Comparison by Usage
      • Exhibit 53: Chart on Comparison by Usage
      • Exhibit 54: Data Table on Comparison by Usage
    • 7.3 Implantable - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Implantable - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Implantable - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Implantable - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Implantable - Year-over-year growth 2022-2027 (%)
    • 7.4 Extracorporeal - Market size and forecast 2022-2027
      • Exhibit 59: Chart on Extracorporeal - Market size and forecast 2022-2027 ($ million)
      • Exhibit 60: Data Table on Extracorporeal - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Chart on Extracorporeal - Year-over-year growth 2022-2027 (%)
      • Exhibit 62: Data Table on Extracorporeal - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Usage
      • Exhibit 63: Market opportunity by Usage ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 65: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 67: Chart on Geographic comparison
      • Exhibit 68: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 Japan - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.11 France - Market size and forecast 2022-2027
      • Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 105: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 108: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 109: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 110: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 111: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 112: Abbott Laboratories - Overview
              • Exhibit 113: Abbott Laboratories - Business segments
              • Exhibit 114: Abbott Laboratories - Key news
              • Exhibit 115: Abbott Laboratories - Key offerings
              • Exhibit 116: Abbott Laboratories - Segment focus
            • 12.4 Asahi Kasei Corp.
              • Exhibit 117: Asahi Kasei Corp. - Overview
              • Exhibit 118: Asahi Kasei Corp. - Business segments
              • Exhibit 119: Asahi Kasei Corp. - Key news
              • Exhibit 120: Asahi Kasei Corp. - Key offerings
              • Exhibit 121: Asahi Kasei Corp. - Segment focus
            • 12.5 B. Braun SE
              • Exhibit 122: B. Braun SE - Overview
              • Exhibit 123: B. Braun SE - Business segments
              • Exhibit 124: B. Braun SE - Key news
              • Exhibit 125: B. Braun SE - Key offerings
              • Exhibit 126: B. Braun SE - Segment focus
            • 12.6 Baxter International Inc.
              • Exhibit 127: Baxter International Inc. - Overview
              • Exhibit 128: Baxter International Inc. - Business segments
              • Exhibit 129: Baxter International Inc. - Key news
              • Exhibit 130: Baxter International Inc. - Key offerings
              • Exhibit 131: Baxter International Inc. - Segment focus
            • 12.7 BioTelemetry Inc.
              • Exhibit 132: BioTelemetry Inc. - Overview
              • Exhibit 133: BioTelemetry Inc. - Product / Service
              • Exhibit 134: BioTelemetry Inc. - Key offerings
            • 12.8 BIOTRONIK SE and Co. KG
              • Exhibit 135: BIOTRONIK SE and Co. KG - Overview
              • Exhibit 136: BIOTRONIK SE and Co. KG - Product / Service
              • Exhibit 137: BIOTRONIK SE and Co. KG - Key offerings
            • 12.9 BiVACOR Inc.
              • Exhibit 138: BiVACOR Inc. - Overview
              • Exhibit 139: BiVACOR Inc. - Product / Service
              • Exhibit 140: BiVACOR Inc. - Key offerings
            • 12.10 Boston Scientific Corp.
              • Exhibit 141: Boston Scientific Corp. - Overview
              • Exhibit 142: Boston Scientific Corp. - Business segments
              • Exhibit 143: Boston Scientific Corp. - Key news
              • Exhibit 144: Boston Scientific Corp. - Key offerings
              • Exhibit 145: Boston Scientific Corp. - Segment focus
            • 12.11 Cochlear Ltd.
              • Exhibit 146: Cochlear Ltd. - Overview
              • Exhibit 147: Cochlear Ltd. - Business segments
              • Exhibit 148: Cochlear Ltd. - Key offerings
              • Exhibit 149: Cochlear Ltd. - Segment focus
            • 12.12 F. Hoffmann La Roche Ltd.
              • Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.13 Fresenius Medical Care AG and Co. KGaA
              • Exhibit 155: Fresenius Medical Care AG and Co. KGaA - Overview
              • Exhibit 156: Fresenius Medical Care AG and Co. KGaA - Business segments
              • Exhibit 157: Fresenius Medical Care AG and Co. KGaA - Key news
              • Exhibit 158: Fresenius Medical Care AG and Co. KGaA - Key offerings
              • Exhibit 159: Fresenius Medical Care AG and Co. KGaA - Segment focus
            • 12.14 Insulet Corp.
              • Exhibit 160: Insulet Corp. - Overview
              • Exhibit 161: Insulet Corp. - Product / Service
              • Exhibit 162: Insulet Corp. - Key news
              • Exhibit 163: Insulet Corp. - Key offerings
            • 12.15 MED EL Elektromedizinische Gerate GmbH
              • Exhibit 164: MED EL Elektromedizinische Gerate GmbH - Overview
              • Exhibit 165: MED EL Elektromedizinische Gerate GmbH - Product / Service
              • Exhibit 166: MED EL Elektromedizinische Gerate GmbH - Key offerings
            • 12.16 Medtronic Plc
              • Exhibit 167: Medtronic Plc - Overview
              • Exhibit 168: Medtronic Plc - Business segments
              • Exhibit 169: Medtronic Plc - Key news
              • Exhibit 170: Medtronic Plc - Key offerings
              • Exhibit 171: Medtronic Plc - Segment focus
            • 12.17 Nipro Pharma Packaging International NV
              • Exhibit 172: Nipro Pharma Packaging International NV - Overview
              • Exhibit 173: Nipro Pharma Packaging International NV - Business segments
              • Exhibit 174: Nipro Pharma Packaging International NV - Key news
              • Exhibit 175: Nipro Pharma Packaging International NV - Key offerings
              • Exhibit 176: Nipro Pharma Packaging International NV - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 177: Inclusions checklist
                • Exhibit 178: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 179: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 180: Research methodology
                • Exhibit 181: Validation techniques employed for market sizing
                • Exhibit 182: Information sources
              • 13.5 List of abbreviations
                • Exhibit 183: List of abbreviations
              • In October, the company appointed Wayne A. I. Frederick to its board of directors.

                Research Framework

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                TechnavioINFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases
                Technavio

                TechnavioDATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts
                Technavio

                TechnavioREPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape
                Interested in this report?
                Get your sample now!
                Artificial Organs market growth will increase by $13089.17 million during 2023-2027.
                The artificial organs market is expected to grow at a CAGR of 9.14% during 2023-2027.
                Technavio has segmented the artificial organs market by product (Artificial heart, Artificial kidney, Cochlear implants, and Artificial pancreas) ,usage (Implantable, Extracorporeal, APAC, South America, and MEA) , and geography (North America, Europe, Asia, and Rest of World (ROW)).
                Abbott Laboratories, Asahi Kasei Corp., B. Braun SE, Baxter International Inc., BioTelemetry Inc., BIOTRONIK SE and Co. KG, BiVACOR Inc., Boston Scientific Corp., Cochlear Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, Insulet Corp., MED EL Elektromedizinische Gerate GmbH, Medtronic Plc, Nihon Kohden Corp., Nikkiso Co. Ltd., Nipro Pharma Packaging International NV, Sonova AG, SynCardia Systems LLC, Tandem Diabetes Care Inc. are a few of the key vendors in the artificial organs market.
                North America will register the highest growth rate of 46.23% among the other regions. Therefore, the artificial organs market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
                The key factors driving the artificial organs market growth are:
                • Increasing prevalence of chronic disorders
                • Emergence of TAH
                The artificial organs market vendors should focus on grabbing business opportunities from the artificial heart segment as it accounted for the largest market share in the base year.
                • What are the key global market and the regional market share?
                • What are the revenue-generating key market segments?
                • What are the key factors driving and challenging this market’s growth?
                • Who are the key market vendors and their growth strategies?
                • What are the latest trends influencing the growth of this market?
                • What are the variables influencing the market growth in the primary regions?
                • What are the factors influencing the growth of the parent market?
                • Off-the-shelf research reports
                • Reports can be tailored to meet the customer's needs
                • Trusted by more than 100 fortune 500 organizations
                • Information about the market's key drivers, trends, and challenges
                • Parent market analysis
                • Every week, 50,000 people visit our subscription platform
                • Detailed vendors report with competitive landscape
                • Covid-19 impact and recovery analysis
                • Data on revenue-generating market segments
                • Details on the market shares of various regions
                • Five-force market analysis

                Certified ISO 9001 : 2015

                We are ISO recognized

                We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

                We are GDPR and CCPA compliant

                We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

                Safe and Secure SSL Encrypted
                Technavio

                info
                close
                • Single:

                  One user only.
                  Quick & easy download option

                • Enterprise:

                  Unlimited user access (Within your organization)
                  Complimentary Customization Included

                2500 USD

                Technavio Get the report (PDF) sent to your email within minutes.

                Subscribe & Save

                Get lifetime access to our
                Technavio Insights

                Customized Report as per your Business Needs

                • Our analysts will work directly with you and understand your needs
                • Get data on specified regions or segments, competitor and Vendors
                • Data will be formatted and presented as per your requirements
                • We offer $1000 worth of FREE customization at the time of purchase

                Let us help you make report more suited to your requirements.

                • Get a competitive breakdown as per your niche industry
                • Customize the data with various metrics that meet your business prerequisite
                • Understand Revenue Sources, Customers and many more
                • Details on Market Share
                • These customizations are done in a short amount of time by our analysts and industry experts
                Technavio
                Enquire Before Buying
                17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>